Illumina, Inc. (ILMN), Pioneer Natural Resources (PXD), Valeant Pharmaceuticals Intl Inc (VRX): Can Andreas Halvorsen’s Top Picks Outperform Mr. Market?

Page 2 of 2

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is the second healthcare company that appears on the list of Viking’s top five largest holdings. In fact, the healthcare sector amasses the largest portion of the fund’s equity portfolio (around 30%). In Valeant, however, Viking cut its stake by 19% during the July-September period to some 9.97 million shares which have a total value of $1.31 billion and represent 5.3% of the total equity portfolio value. The fund has been a long-term investor in Valeant Pharmaceuticals Intl Inc (NYSE:VRX); it first disclosed holding shares in the company as of the end of the second quarter of 2010, while the stock gained more than 600% since then. The largest shareholder in the specialty pharmaceutical company among the funds that we track is Jeffrey Ubben’s Valueact Capital, which owned 18.92 million shares of the company at the end of September, and  increased its stake to 19.13 million shares around a week ago. Mr. Ubben has been recently appointed to Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s board of directors.

In Walgreen Company (NYSE:WAG) and Lowe’s Companies, Inc. (NYSE:LOW), Viking disclosed holding around 20.71 million shares and 19.42 million shares respectively. Both positions amass between 4% and 5% of the fund’s equity portfolio.

Disclosure: none

Page 2 of 2